
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $393.6M | $550.6M | $741.6M | $817.3M | $879.2M | |
Revenue Growth (YoY) | -12.29% | 39.89% | 34.69% | 10.21% | 7.57% | |
Cost of Revenues | $33.5M | $35.1M | $47.3M | $43.5M | $46M | |
Gross Profit | $360.1M | $515.4M | $694.3M | $773.8M | $833.2M | |
Gross Profit Margin | 91.48% | 93.62% | 93.63% | 94.68% | 94.76% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $89.7M | $123.4M | $163.1M | $198.6M | $195.1M | |
Other Inc / (Exp) | $3.9M | $977K | $31.8M | -$15.1M | -$80.1M | |
Operating Expenses | $322.2M | $403.6M | $529.6M | $585M | $600.1M | |
Operating Income | $37.8M | $111.9M | $164.7M | $188.8M | $233.1M | |
Net Interest Expenses | $40.9M | $44.9M | $69.4M | $86.7M | $73.9M | |
EBT. Incl. Unusual Items | $853K | $67.9M | $127.1M | $87M | $79.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $5.4M | $26.5M | $34.6M | $30M | $47.7M | |
Net Income to Company | -$4.6M | $41.4M | $92.5M | $57M | $31.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$4.6M | $41.4M | $92.5M | $57M | $31.4M | |
Basic EPS (Cont. Ops) | -$0.03 | $0.26 | $0.61 | $0.36 | $0.19 | |
Diluted EPS (Cont. Ops) | -$0.03 | $0.25 | $0.50 | $0.36 | $0.19 | |
Weighted Average Basic Share | $161.6M | $160M | $152.8M | $158.8M | $165.1M | |
Weighted Average Diluted Share | $161.6M | $163.8M | $159M | $160M | $167.7M | |
EBITDA | $158.6M | $229.6M | $336.7M | $286.9M | $262.1M | |
EBIT | $41.7M | $112.8M | $196.5M | $173.7M | $153M | |
Revenue (Reported) | $393.6M | $550.6M | $741.6M | $817.3M | $879.2M | |
Operating Income (Reported) | $37.8M | $111.9M | $164.7M | $188.8M | $233.1M | |
Operating Income (Adjusted) | $41.7M | $112.8M | $196.5M | $173.7M | $153M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $89.9M | $170.4M | $191.9M | $209.7M | $223.3M | |
Revenue Growth (YoY) | -23.01% | 89.62% | 12.63% | 9.29% | 6.45% | |
Cost of Revenues | $907K | $9.8M | $9.6M | $9.6M | $12.8M | |
Gross Profit | $89M | $160.6M | $182.3M | $200.1M | $210.4M | |
Gross Profit Margin | 98.99% | 94.26% | 94.99% | 95.43% | 94.26% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $28.4M | $41.6M | $40M | $48.2M | $51.5M | |
Other Inc / (Exp) | -$4.4M | -$868K | -$15M | $4.3M | $4.1M | |
Operating Expenses | $87.2M | $128.6M | $132.2M | $145.8M | $153.1M | |
Operating Income | $1.8M | $32M | $50.1M | $54.4M | $57.4M | |
Net Interest Expenses | $9.2M | $14.3M | $22.7M | $19.6M | $16.6M | |
EBT. Incl. Unusual Items | -$11.8M | $16.9M | $12.4M | $39M | $44.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$2.9M | $6.8M | $7.8M | $9.8M | $12.5M | |
Net Income to Company | -$8.9M | $10M | $4.6M | $29.1M | $32.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$8.9M | $10M | $4.6M | $29.1M | $32.3M | |
Basic EPS (Cont. Ops) | -$0.05 | $0.06 | $0.03 | $0.18 | $0.20 | |
Diluted EPS (Cont. Ops) | -$0.05 | $0.06 | $0.03 | $0.17 | $0.20 | |
Weighted Average Basic Share | $162.3M | $156.1M | $149.2M | $166.2M | $159.5M | |
Weighted Average Diluted Share | $162.3M | $160.7M | $153.1M | $168.7M | $162.1M | |
EBITDA | $25.6M | $67M | $65.4M | $85.6M | $89.3M | |
EBIT | -$2.6M | $31.1M | $35.1M | $58.6M | $61.5M | |
Revenue (Reported) | $89.9M | $170.4M | $191.9M | $209.7M | $223.3M | |
Operating Income (Reported) | $1.8M | $32M | $50.1M | $54.4M | $57.4M | |
Operating Income (Adjusted) | -$2.6M | $31.1M | $35.1M | $58.6M | $61.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $366.7M | $631.1M | $763.1M | $835.1M | $892.7M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $24.5M | $44M | $47.1M | $43.4M | $49.3M | |
Gross Profit | $342.2M | $587.1M | $716M | $791.7M | $843.5M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $92.2M | $136.6M | $161.5M | $206.7M | $198.4M | |
Other Inc / (Exp) | -$18.9M | $4.5M | $17.7M | $4.1M | -$80.3M | |
Operating Expenses | $322M | $445M | $533.2M | $598.6M | $607.3M | |
Operating Income | $20.2M | $142.1M | $182.8M | $193.1M | $236.1M | |
Net Interest Expenses | $37.6M | $50.1M | $77.8M | $83.6M | $70.9M | |
EBT. Incl. Unusual Items | -$36.3M | $96.6M | $122.7M | $113.5M | $85M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$669K | $36.2M | $35.7M | $32M | $50.3M | |
Net Income to Company | -$35.6M | $60.4M | $87M | $81.6M | $34.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$35.6M | $60.4M | $87M | $81.6M | $34.6M | |
Basic EPS (Cont. Ops) | -$0.14 | $0.37 | $0.57 | $0.50 | $0.21 | |
Diluted EPS (Cont. Ops) | -$0.14 | $0.34 | $0.46 | $0.49 | $0.20 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $117.1M | $271.1M | $335.1M | $307.1M | $265.8M | |
EBIT | $1.3M | $146.6M | $200.5M | $197.2M | $155.9M | |
Revenue (Reported) | $366.7M | $631.1M | $763.1M | $835.1M | $892.7M | |
Operating Income (Reported) | $20.2M | $142.1M | $182.8M | $193.1M | $236.1M | |
Operating Income (Adjusted) | $1.3M | $146.6M | $200.5M | $197.2M | $155.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $89.9M | $170.4M | $191.9M | $209.7M | $223.3M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $907K | $9.8M | $9.6M | $9.6M | $12.8M | |
Gross Profit | $89M | $160.6M | $182.3M | $200.1M | $210.4M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $28.4M | $41.6M | $40M | $48.2M | $51.5M | |
Other Inc / (Exp) | -$4.4M | -$868K | -$15M | $4.3M | $4.1M | |
Operating Expenses | $87.2M | $128.6M | $132.2M | $145.8M | $153.1M | |
Operating Income | $1.8M | $32M | $50.1M | $54.4M | $57.4M | |
Net Interest Expenses | $9.2M | $14.3M | $22.7M | $19.6M | $16.6M | |
EBT. Incl. Unusual Items | -$11.8M | $16.9M | $12.4M | $39M | $44.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$2.9M | $6.8M | $7.8M | $9.8M | $12.5M | |
Net Income to Company | -$8.9M | $10M | $4.6M | $29.1M | $32.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$8.9M | $10M | $4.6M | $29.1M | $32.3M | |
Basic EPS (Cont. Ops) | -$0.05 | $0.06 | $0.03 | $0.18 | $0.20 | |
Diluted EPS (Cont. Ops) | -$0.05 | $0.06 | $0.03 | $0.17 | $0.20 | |
Weighted Average Basic Share | $162.3M | $156.1M | $149.2M | $166.2M | $159.5M | |
Weighted Average Diluted Share | $162.3M | $160.7M | $153.1M | $168.7M | $162.1M | |
EBITDA | $25.6M | $67M | $65.4M | $85.6M | $89.3M | |
EBIT | -$2.6M | $31.1M | $35.1M | $58.6M | $61.5M | |
Revenue (Reported) | $89.9M | $170.4M | $191.9M | $209.7M | $223.3M | |
Operating Income (Reported) | $1.8M | $32M | $50.1M | $54.4M | $57.4M | |
Operating Income (Adjusted) | -$2.6M | $31.1M | $35.1M | $58.6M | $61.5M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $120.3M | $101.3M | $105.2M | $136.3M | $77.6M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $168.8M | $161M | $163.8M | $197.8M | $206.5M | |
Inventory | $113K | $12.1M | $19.3M | $18M | $15.5M | |
Prepaid Expenses | $23.4M | $38.1M | $36.4M | $30.5M | $31.5M | |
Other Current Assets | $777K | -- | -- | $757K | $4.4M | |
Total Current Assets | $328M | $348.1M | $362.6M | $439.5M | $394M | |
Property Plant And Equipment | $108M | $148.3M | $170.3M | $179.7M | $208.1M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $586.4M | $838.9M | $833.5M | $835.8M | $735.6M | |
Other Intangibles | $342.1M | $487.3M | $377.4M | $301M | $232.3M | |
Other Long-Term Assets | $2.7M | $14.6M | $12.5M | $33.9M | $44.5M | |
Total Assets | $1.4B | $1.8B | $1.8B | $1.8B | $1.6B | |
Accounts Payable | $34.5M | $67.6M | $79.9M | $78.7M | $91.2M | |
Accrued Expenses | $7.7M | $27.1M | $29.4M | $73.3M | $53.6M | |
Current Portion Of Long-Term Debt | $9.1M | $37M | $21.9M | $9M | -- | |
Current Portion Of Capital Lease Obligations | $3.2M | $5.8M | $6.4M | $7.1M | $6.9M | |
Other Current Liabilities | -- | $5.1M | $6M | $5.1M | $5.2M | |
Total Current Liabilities | $64M | $175.2M | $186.8M | $214.8M | $199.7M | |
Long-Term Debt | $832.9M | $1.2B | $1.2B | $1B | $1B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.1B | $1.6B | $1.5B | $1.4B | $1.3B | |
Common Stock | $16K | $16K | $15K | $17K | $16K | |
Other Common Equity Adj | $211K | -$5.1M | -$12.9M | -$10.2M | -$17.6M | |
Common Equity | $315.6M | $260M | $231.1M | $421.5M | $265.1M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $315.6M | $260M | $231.1M | $421.5M | $265.1M | |
Total Liabilities and Equity | $1.4B | $1.8B | $1.8B | $1.8B | $1.6B | |
Cash and Short Terms | $120.3M | $101.3M | $105.2M | $136.3M | $77.6M | |
Total Debt | $842M | $1.2B | $1.2B | $1B | $1B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $249.6M | $93.4M | $64.3M | $149.5M | $108.5M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $193M | $171.9M | $178.3M | $182M | $212.1M | |
Inventory | -- | $15.5M | $18.9M | $17.3M | $16M | |
Prepaid Expenses | $22.9M | $35M | $28.5M | $36M | $29.1M | |
Other Current Assets | $1.6M | $1.3M | $325K | $1.3M | $3.6M | |
Total Current Assets | $482.8M | $363M | $332.4M | $438.6M | $426.1M | |
Property Plant And Equipment | $106.5M | $154.8M | $175.9M | $180.4M | $217.1M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $586.2M | $837.9M | $834.3M | $834.6M | $737.6M | |
Other Intangibles | $319.1M | $460.1M | $355.7M | $283.4M | $216M | |
Other Long-Term Assets | $2.5M | $8.7M | $12.6M | $32.9M | $46.4M | |
Total Assets | $1.5B | $1.8B | $1.7B | $1.8B | $1.6B | |
Accounts Payable | $41.3M | $63M | $71.5M | $75.6M | $89.8M | |
Accrued Expenses | $10.9M | $27.6M | $32.4M | $31.8M | $41.5M | |
Current Portion Of Long-Term Debt | $6.5M | $12M | $9M | -- | -- | |
Current Portion Of Capital Lease Obligations | $3.2M | $6M | $6.9M | $6.7M | $6.9M | |
Other Current Liabilities | -- | -- | $6.4M | $5.1M | $5.2M | |
Total Current Liabilities | $70.4M | $154.1M | $168.6M | $159.4M | $194.8M | |
Long-Term Debt | $965.9M | $1.2B | $1.1B | $1B | $1B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.2B | $1.5B | $1.5B | $1.3B | $1.3B | |
Common Stock | $16K | $16K | $15K | $17K | $16K | |
Other Common Equity Adj | $21K | -$2.4M | -$13M | -$13.4M | -$15.4M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $308.5M | $275.8M | $237.1M | $449M | $299.6M | |
Total Liabilities and Equity | $1.5B | $1.8B | $1.7B | $1.8B | $1.6B | |
Cash and Short Terms | $249.6M | $93.4M | $64.3M | $149.5M | $108.5M | |
Total Debt | $972.4M | $1.2B | $1.1B | $1B | $1B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$4.6M | $41.4M | $92.5M | $57M | $31.4M | |
Depreciation & Amoritzation | $116.6M | $116.8M | $138.7M | $113.1M | $108.5M | |
Stock-Based Compensation | $12.6M | $13.8M | $16.7M | $17.5M | $23M | |
Change in Accounts Receivable | -$84.6M | $7.2M | -$19.6M | -$48.7M | -$34.7M | |
Change in Inventories | -- | $2.8M | -$10.3M | $1.1M | $1.9M | |
Cash From Operations | $46.9M | $193.2M | $218.3M | $206.1M | $223.6M | |
Capital Expenditures | $24.3M | $25M | $48.2M | $57.5M | $70.9M | |
Cash Acquisitions | -- | -$451.2M | -$647K | -- | -- | |
Cash From Investing | -$24.2M | -$476M | -$48.6M | -$58.3M | -$69.7M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | $1.3B | -- | -- | $36.6M | |
Long-Term Debt Repaid | -$28.8M | -$884.5M | -$34M | -$181.5M | -$45.6M | |
Repurchase of Common Stock | -- | -$100M | -$125.1M | -$100M | -$200M | |
Other Financing Activities | -$5.2M | -$17.4M | -$7.2M | -$3.6M | -$6.7M | |
Cash From Financing | -$34M | $268.7M | -$164.9M | -$117.8M | -$211.4M | |
Beginning Cash (CF) | $132.4M | $120.9M | $104.4M | $109.1M | $139.7M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$11.2M | -$14.1M | $4.8M | $30M | -$57.5M | |
Ending Cash (CF) | $120.9M | $104.4M | $109.1M | $139.7M | $81.2M | |
Levered Free Cash Flow | $22.6M | $168.2M | $170.2M | $148.6M | $152.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$8.9M | $10M | $4.6M | $29.1M | $32.3M | |
Depreciation & Amoritzation | $28.2M | $35.7M | $30.3M | $26.9M | $27.5M | |
Stock-Based Compensation | $2.9M | $4.4M | $3.4M | $5.6M | $6.5M | |
Change in Accounts Receivable | -$27.5M | -$24.6M | -$19.7M | $3.7M | -$12M | |
Change in Inventories | -$691K | -$5.7M | $180K | $479K | $237K | |
Cash From Operations | $9M | $31.2M | $45.2M | $34.3M | $63M | |
Capital Expenditures | $3.7M | $11.5M | $18.4M | $14.3M | $21.2M | |
Cash Acquisitions | -- | -$412K | -- | -- | -- | |
Cash From Investing | -$3.6M | -$11.9M | -$19.6M | -$13.9M | -$21.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $996.8M | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$865.6M | -$27.3M | -$64.8M | -$2.3M | -$2.3M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$7.2M | -$1.5M | -$2.6M | -$4.7M | -$6.6M | |
Cash From Financing | $123.9M | -$28.7M | -$66.6M | -$6.3M | -$8.7M | |
Beginning Cash (CF) | $120.9M | $104.4M | $109.1M | $139.7M | $81.2M | |
Foreign Exchange Rate Adjustment | $252K | $2.2M | -$305K | -$608K | $365K | |
Additions / Reductions | $129.3M | -$9.3M | -$41M | $14.1M | $33M | |
Ending Cash (CF) | $250.4M | $97.4M | $67.8M | $153.2M | $114.5M | |
Levered Free Cash Flow | $5.3M | $19.8M | $26.8M | $20.1M | $41.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$35.6M | $60.4M | $87M | $81.6M | $34.6M | |
Depreciation & Amoritzation | $115.5M | $124.2M | $133.3M | $109.6M | $109.1M | |
Stock-Based Compensation | $12.7M | $15.3M | $15.6M | $19.7M | $23.9M | |
Change in Accounts Receivable | -$93.4M | $10.2M | -$14.7M | -$25.3M | -$50.4M | |
Change in Inventories | -- | -$2.2M | -$4.4M | $1.4M | $1.7M | |
Cash From Operations | $41.1M | $215.4M | $232.3M | $195.2M | $252.3M | |
Capital Expenditures | $19.8M | $32.8M | $55.1M | $53.4M | $77.8M | |
Cash Acquisitions | -- | -$451.6M | -$235K | -- | -- | |
Cash From Investing | -$19.7M | -$484.2M | -$56.3M | -$52.6M | -$77M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $996.8M | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$872.5M | -$46.1M | -$71.5M | -$119M | -$45.6M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$11.3M | -$11.7M | -$8.3M | -$5.7M | -$8.7M | |
Cash From Financing | $113M | $116.2M | -$202.9M | -$57.4M | -$213.9M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $134.4M | -$152.6M | -$26.9M | $85.1M | -$38.6M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $21.3M | $182.6M | $177.2M | $141.8M | $174.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$8.9M | $10M | $4.6M | $29.1M | $32.3M | |
Depreciation & Amoritzation | $28.2M | $35.7M | $30.3M | $26.9M | $27.5M | |
Stock-Based Compensation | $2.9M | $4.4M | $3.4M | $5.6M | $6.5M | |
Change in Accounts Receivable | -$27.5M | -$24.6M | -$19.7M | $3.7M | -$12M | |
Change in Inventories | -$691K | -$5.7M | $180K | $479K | $237K | |
Cash From Operations | $9M | $31.2M | $45.2M | $34.3M | $63M | |
Capital Expenditures | $3.7M | $11.5M | $18.4M | $14.3M | $21.2M | |
Cash Acquisitions | -- | -$412K | -- | -- | -- | |
Cash From Investing | -$3.6M | -$11.9M | -$19.6M | -$13.9M | -$21.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $996.8M | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$865.6M | -$27.3M | -$64.8M | -$2.3M | -$2.3M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$7.2M | -$1.5M | -$2.6M | -$4.7M | -$6.6M | |
Cash From Financing | $123.9M | -$28.7M | -$66.6M | -$6.3M | -$8.7M | |
Beginning Cash (CF) | $120.9M | $104.4M | $109.1M | $139.7M | $81.2M | |
Foreign Exchange Rate Adjustment | $252K | $2.2M | -$305K | -$608K | $365K | |
Additions / Reductions | $129.3M | -$9.3M | -$41M | $14.1M | $33M | |
Ending Cash (CF) | $250.4M | $97.4M | $67.8M | $153.2M | $114.5M | |
Levered Free Cash Flow | $5.3M | $19.8M | $26.8M | $20.1M | $41.7M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.